Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methylphenidate hydrochloride 10 mg oral tablet |
Is a |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 36mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 18mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 20 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 18 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 36 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 10 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 10 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 20 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 27 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 54 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 30 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 40 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 2 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidathydrochlorid 72 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidat 10 mg tyggetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidat 5 mg tyggetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
methylphenidat 2,5 mg tyggetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 72mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 10mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely methylphenidate hydrochloride 18 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 18 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 20 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 20 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 50 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 50 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 10 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 10 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 36 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 36 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 54 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 54 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 27 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 27 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 40 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 40 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 2 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 2 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg chewable tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 10 mg chewable tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 10 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |
Methylphenidate hydrochloride 5 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenidate hydrochloride |
Inferred relationship |
Some |
1 |